Ipratropium Bromide | CAS#22254-24-6

MedKoo Cat#: 527045 | Name: Ipratropium Bromide

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Ipratropium Bromide is a muscarinic antagonist, bronchodilator. N-Isopropylated atropine.

Chemical Structure

Ipratropium Bromide

CAS#22254-24-6 (bromide)

Theoretical Analysis

MedKoo Cat#: 527045

Name: Ipratropium Bromide

CAS#: 22254-24-6 (bromide)

Chemical Formula: C20H30BrNO3

Exact Mass: 411.1409

Molecular Weight: 412.37

Elemental Analysis: C, 58.25; H, 7.33; Br, 19.38; N, 3.40; O, 11.64

Price and Availability

This product was removed for the commercial reasons.

Related CAS #

60205-81-4 (cation) 22254-24-6 (bromide) 66985-17-9 (bromide hydrate) 922491-06-3 (bromide hydrate)

Synonym

Ipratropium Bromide

IUPAC/Chemical Name

(endo,syn)-(±)-3-(3-Hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-8-azoniabicyclo[3.2.1]octane bromide

InChi Key

LHLMOSXCXGLMMN-UHFFFAOYSA-M

InChi Code

InChI=1S/C20H30NO3.BrH/c1-14(2)21(3)16-9-10-17(21)12-18(11-16)24-20(23)19(13-22)15-7-5-4-6-8-15;/h4-8,14,16-19,22H,9-13H2,1-3H3;1H/q+1;/p-1

SMILES Code

CC([N+]1(C)C2CC(OC(C(C3=CC=CC=C3)CO)=O)CC1CC2)C.[Br-]

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>2 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 412.37 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Bräunlich J, Wirtz H. Oral Versus Nasal High-Flow Bronchodilator Inhalation in Chronic Obstructive Pulmonary Disease. J Aerosol Med Pulm Drug Deliv. 2017 Dec 20. doi: 10.1089/jamp.2017.1432. [Epub ahead of print] PubMed PMID: 29261402. 2: Pejic R, Klaric B. Transient anisocoria in a patient treated with nebulized ipratropium bromide. Am J Ophthalmol Case Rep. 2017 Apr 12;7:11-13. doi: 10.1016/j.ajoc.2017.04.005. eCollection 2017 Sep. PubMed PMID: 29260071; PubMed Central PMCID: PMC5722162. 3: Bar-Aluma BE, Efrati O, Kaufmann H, Palma JA, Norcliffe-Kaufmann L. A Controlled Trial of Inhaled Bronchodilators in Familial Dysautonomia. Lung. 2017 Dec 12. doi: 10.1007/s00408-017-0073-7. [Epub ahead of print] PubMed PMID: 29234869. 4: Jiang DH, Wang X, Liu LS, Ji DD, Zhang N. The effect of ventilator mask atomization inhalation of ipratropium bromide and budesonide suspension liquid in the treatment of COPD in acute exacerbation period on circulating levels of inflammation and prognosis. Eur Rev Med Pharmacol Sci. 2017 Nov;21(22):5211-5216. doi: 10.26355/eurrev_201711_13843. PubMed PMID: 29228436. 5: Knightly R, Milan SJ, Hughes R, Knopp-Sihota JA, Rowe BH, Normansell R, Powell C. Inhaled magnesium sulfate in the treatment of acute asthma. Cochrane Database Syst Rev. 2017 Nov 28;11:CD003898. doi: 10.1002/14651858.CD003898.pub6. Review. PubMed PMID: 29182799. 6: Lin X, Fan Y, Wang X, Chi M, Li X, Zhang X, Sun D. Correlation Between Tumor Necrosis Factor-α and Interleukin-1β in Exhaled Breath Condensate and Pulmonary Function. Am J Med Sci. 2017 Oct;354(4):388-394. doi: 10.1016/j.amjms.2017.06.004. Epub 2017 Jun 12. PubMed PMID: 29078843. 7: Yang SH, Yang TM, Lin HL, Tsai YH, Fang TP, Wan GH. Size distribution of salbutamol/ipratropium aerosols produced by different nebulizers in the absence and presence of heat and humidification. Pulm Pharmacol Ther. 2017 Oct 17. pii: S1094-5539(17)30208-0. doi: 10.1016/j.pupt.2017.10.009. [Epub ahead of print] PubMed PMID: 29054517. 8: Famularo G, Sordillo P, Stasolla A, Parisi MG. A 58-Year-Old Woman With Pneumonia and Gram-Negative Diplococci. Chest. 2017 Oct;152(4):e95-e97. doi: 10.1016/j.chest.2017.05.037. PubMed PMID: 28991556. 9: Quinn D, Barnes CN, Yates W, Bourdet DL, Moran EJ, Potgieter P, Nicholls A, Haumann B, Singh D. Pharmacodynamics, pharmacokinetics and safety of revefenacin (TD-4208), a long-acting muscarinic antagonist, in patients with chronic obstructive pulmonary disease (COPD): Results of two randomized, double-blind, phase 2 studies. Pulm Pharmacol Ther. 2017 Oct 4. pii: S1094-5539(17)30119-0. doi: 10.1016/j.pupt.2017.10.003. [Epub ahead of print] PubMed PMID: 28987804. 10: Portran P, Cour M, Hernu R, de la Salle S, Argaud L. Pupillary abnormalities in non-selected critically ill patients: an observational study. J Thorac Dis. 2017 Aug;9(8):2528-2533. doi: 10.21037/jtd.2017.07.58. PubMed PMID: 28932559; PubMed Central PMCID: PMC5594163. 11: Hou M, Li W, Xie Z, Ai J, Sun B, Tan G. Effects of anticholinergic agent on miRNA profiles and transcriptomes in a murine model of allergic rhinitis. Mol Med Rep. 2017 Nov;16(5):6558-6569. doi: 10.3892/mmr.2017.7411. Epub 2017 Aug 31. PubMed PMID: 28901404. 12: Duong HV, Herrera LN, Moore JX, Donnelly J, Jacobson KE, Carlson JN, Mann NC, Wang HE. National Characteristics of Emergency Medical Services Responses for Older Adults in the United States. Prehosp Emerg Care. 2017 Sep 1:1-8. doi: 10.1080/10903127.2017.1347223. [Epub ahead of print] PubMed PMID: 28862480. 13: Panduga V, Stocks MJ, Bosquillon C. Ipratropium is 'luminally recycled' by an inter-play between apical uptake and efflux transporters in Calu-3 bronchial epithelial cell layers. Int J Pharm. 2017 Oct 30;532(1):328-336. doi: 10.1016/j.ijpharm.2017.08.112. PubMed PMID: 28855136. 14: Nomura O, Morikawa Y, Hagiwara Y, Ihara T, Inoue N, Sakakibara H, Akasawa A. IPRATROPIUM BROMIDE FOR ACUTE ASTHMA IN CHILDREN: A RETROSPECTIVE TRIAL. Arerugi. 2017;66(7):945-952. doi: 10.15036/arerugi.66.945. Japanese. PubMed PMID: 28824036. 15: Halpin DM, Kaplan AG, Russell RK. Why choose tiotropium for my patient? A comprehensive review of actions and outcomes versus other bronchodilators. Respir Med. 2017 Jul;128:28-41. doi: 10.1016/j.rmed.2017.04.008. Epub 2017 Apr 18. Review. PubMed PMID: 28610667. 16: Rehder KJ. Adjunct Therapies for Refractory Status Asthmaticus in Children. Respir Care. 2017 Jun;62(6):849-865. doi: 10.4187/respcare.05174. PubMed PMID: 28546381. 17: Lee TM, Tu K, Wing LL, Gershon AS. Identifying individuals with physician-diagnosed chronic obstructive pulmonary disease in primary care electronic medical records: a retrospective chart abstraction study. NPJ Prim Care Respir Med. 2017 May 15;27(1):34. doi: 10.1038/s41533-017-0035-9. PubMed PMID: 28507288; PubMed Central PMCID: PMC5435091. 18: Li X, Obeidat M, Zhou G, Leung JM, Tashkin D, Wise R, Connett J, Joubert P, Bossé Y, van den Berge M, Brandsma CA, Nickle DC, Hao K, Paré PD, Sin DD. Responsiveness to Ipratropium Bromide in Male and Female Patients with Mild to Moderate Chronic Obstructive Pulmonary Disease. EBioMedicine. 2017 May;19:139-145. doi: 10.1016/j.ebiom.2017.04.020. Epub 2017 Apr 12. PubMed PMID: 28461224; PubMed Central PMCID: PMC5440622. 19: Liu X, Tang C, Xu H. Clinical effect of treatment on elderly chronic obstructive pulmonary disease combined with pulmonary tuberculosis. Pak J Pharm Sci. 2016 Nov;29(6 Spec):2255-2258. PubMed PMID: 28412691. 20: Bhandari SS, Koirala P, Lohani S, Phuyal P, Basnyat B. Breathlessness at High Altitude: First Episode of Bronchoconstriction in an Otherwise Healthy Sojourner. High Alt Med Biol. 2017 Jun;18(2):179-181. doi: 10.1089/ham.2017.0004. Epub 2017 Feb 21. PubMed PMID: 28398844.